Klinger Shannon Thyme's Form 4 filing
Moderna, Inc. (MRNA) · filed Aug 29, 2024
- Accession no.
- 0001127602-24-023134
- Filed
- Aug 29, 2024
- Trade date
- Aug 27-28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $104.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klinger Shannon ThymeCIK 0001866132 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +2,652 | –F1 | – | 18,599 | Direct | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −1,319 | $79.39 | −$104,715.41 | 17,280 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −2,652 | $0.00 | $0 | 5,305 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert into common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.